RGEN - repligen.com Net Margin

Brandmark of Repligen (RGEN)

The growth of Repligen Corporation (RGEN) is driven by the resurgence of biotech investments in gene therapy. The net profit margin illustrates the resilience of returns, where -1.50 reflects the latest value of the metric. Stability is confirmed by the low cyclicality of bioprocessing and the absence of seasonal fluctuations. Additional protection is guaranteed by the humanitarian status of the products, which minimizes the impact of geopolitical conflicts on global equipment supplies.

Repligen Corporation (RGEN) Net Margin: for the period 07/04/2022 - 11/19/2026

RGEN (Repligen Corporation): analytical breakdowns and indicator data

- market value and analyst target forecast:
- market capitalization statistics:
Fundamental company valuation:Repligen Corp - RGEN
Flagship merchandise of Repligen Inc.

Net margin determines the portion of profit in every dollar of revenue, serving as an integral measure of cost management and pricing efficiency. An analysis of the operating net profit margin of Repligen Corporation (RGEN) allows for an assessment of the profitability of biopharmaceutical systems and consumables sales, where steady growth of this indicator confirms high product added value and creates a fundamental margin of safety for the investor.

Competitors of Repligen Corporation (RGEN)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Avidity (RNA) - Company Sales Margin|Net Sales Margin CRSP|Company Sales Margin GeneDx|Net Margin Ultragenyx RARE|Company Sales Margin Beam Therapeutics (BEAM)|SRPT: Return on Sales by Net Profit|Net Margin Twist Bioscience|TXG (10x Genomics) - Return on Sales by Net Profit|Intellia Therapeutics, Inc. (NTLA) - Net Sales Margin|Net Margin Stoke Therapeutics Inc|BLFS: Net Profit Rate|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX